| 5J0D | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | 6F9, EDO | enzyme |
| ||||||||||||
| Primary reference | Development of Selective CBP/P300 Benzoxazepine Bromodomain Inhibitors., Popp TA, Tallant C, Rogers C, Fedorov O, Brennan PE, Muller S, Knapp S, Bracher F, J Med Chem. 2016 Sep 27. PMID:27673482 | ||||||||||||||
| Data retrieval |
![]() |
| View 5J0D in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |